Fig. 15
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-EZH2 inhibitor
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-EZH2 inhibitor